![](/img/cover-not-exists.png)
Raloxifene reduces procarboxypeptidase U, an antifibrinolytic marker. A 2-year randomized, placebo-controlled study in healthy early postmenopausal women
Vogelvang, Tatjana E., Leurs, Judith R., van der Mooren, Marius J., Mijatovic, Velja, Hendriks, Dirk F., Neele, Simone J.M., Netelenbos, J. Coen, Kenemans, PeterVolume:
11
Language:
english
Journal:
Menopause
DOI:
10.1097/01.gme.0000097740.18446.77
Date:
January, 2004
File:
PDF, 267 KB
english, 2004